Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT06931613
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaChildrenNivolumab+1 more
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04233346
What this trial is testing

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Otsuka Beijing Research Institute 93
Testing effectiveness (Phase 2)Study completedNCT00373646
What this trial is testing

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

Who this might be right for
MALT Lymphoma
Medical University of Vienna 8
Not applicableUnknownNCT03265158
What this trial is testing

Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)
Royal Marsden NHS Foundation Trust 108
Testing effectiveness (Phase 2)Study completedNCT00156013
What this trial is testing

Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin
Oncology Specialists, S.C. 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT03075696
What this trial is testing

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 940
Not applicableActive Not RecruitingNCT01829958
What this trial is testing

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Who this might be right for
Non Hodgkin Lymphoma (NHL)Diffuse Large B-cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center 201
Large-scale testing (Phase 3)Looking for participantsNCT07256158
What this trial is testing

PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 518
Not applicableNot Yet RecruitingNCT07366450
What this trial is testing

High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Vitamin D 25-Hydroxylase DeficiencyLymphoma Non-Hodgkin
Phramongkutklao College of Medicine and Hospital 52
Early research (Phase 1)Study completedNCT01697020
What this trial is testing

Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

Who this might be right for
Acute Lymphoblastic Leukemia
Nova Laboratories Limited 70
Not applicableLooking for participantsNCT07356882
What this trial is testing

European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Assistance Publique - Hôpitaux de Paris 400
Not applicableStudy completedNCT06234280
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100
Not applicableStudy completedNCT01301417
What this trial is testing

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

Who this might be right for
Diverticulum, ColonColorectal NeoplasmsCrohn Disease+8 more
novoGI 171
Not applicableLooking for participantsNCT06534918
What this trial is testing

Precise Oncology Interventions in Nutrition and Training (OnPoint)

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+1 more
University of Miami 306
Testing effectiveness (Phase 2)Looking for participantsNCT07609862
What this trial is testing

Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

Who this might be right for
Mantle Cell Lymphoma (MCL)Diffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)+2 more
Guangzhou Lupeng Pharmaceutical Company LTD. 92
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT01562990
What this trial is testing

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

Who this might be right for
Diffuse Large B-Cell Lymphoma
The Lymphoma Academic Research Organisation 11
Early research (Phase 1)Ended earlyNCT01005979
What this trial is testing

A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellChronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic
Emory University 6
Testing effectiveness (Phase 2)Study completedNCT01958996
What this trial is testing

Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma

Who this might be right for
High Grade Lymphomas CD20 Positive
Poitiers University Hospital 27
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Next Page